Lung Density Changes After Stereotactic Radiotherapy: A Quantitative Analysis in 50 Patients

Palma, David A.; Koste, John van Sörnsen de; Verbakel, Wilko F.A.R.; Vincent, Andrew; Senan, Suresh

doi:10.1016/j.ijrobp.2010.07.025

Cited by 86 publications

(90 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…6 Although most parts of the works in this context faced the detection of RILI by the evaluation of simple CT ; Pota et al, 2015 103 CRT, chemoradiotherapy; DCE-MRI, dynamic contrast-enhanced MRI; EBRT, external beam radiotherapy; IMRT, intensity-modulated radiotherapy; mp-MRI, multiparametric MRI; PET, positron emission tomography; RT, radiotherapy; SABR, stereotactic ablative radiation therapy; SRT, stereotactic radiotherapy; T2w, T 2 weighted. density, [76][77][78] Mattonen et al [79][80][81] proposed texture analysis for an automatic classification of tumour recurrence and lung injuries. They found a radiomic signature consisting of five textural features (minimum grey level, grey-level uniformity, GLCM homogeneity, GLCM correlation and GLCM energy) after stereotactic ablative radiation therapy (SABR) in consolidative and periconsolidative regions.…”

Section: Application Of Texture Analysis In Radiotherapymentioning

confidence: 99%

Texture analysis of medical images for radiotherapy applications

Scalco¹,

Rizzo²

2017

The British Journal of Radiology

127

108

View full text Add to dashboard Cite

The high-throughput extraction of quantitative information from medical images, known as radiomics, has grown in interest due to the current necessity to quantitatively characterize tumour heterogeneity. In this context, texture analysis, consisting of a variety of mathematical techniques that can describe the grey-level patterns of an image, plays an important role in assessing the spatial organization of different tissues and organs. For these reasons, the potentiality of texture analysis in the context of radiotherapy has been widely investigated in several studies, especially for the prediction of the treatment response of tumour and normal tissues. Nonetheless, many different factors can affect the robustness, reproducibility and reliability of textural features, thus limiting the impact of this technique. In this review, an overview of the most recent works that have applied texture analysis in the context of radiotherapy is presented, with particular focus on the assessment of tumour and tissue response to radiations. Preliminary, the main factors that have an influence on features estimation are discussed, highlighting the need of more standardized image acquisition and reconstruction protocols and more accurate methods for region of interest identification. Despite all these limitations, texture analysis is increasingly demonstrating its ability to improve the characterization of intratumour heterogeneity and the prediction of clinical outcome, although prospective studies and clinical trials are required to draw a more complete picture of the full potential of this technique.

show abstract

Section: Application Of Texture Analysis In Radiotherapymentioning

confidence: 99%

Texture analysis of medical images for radiotherapy applications

Scalco¹,

Rizzo²

2017

The British Journal of Radiology

127

108

View full text Add to dashboard Cite

show abstract

“…3,5,[11][12][13] It has been reported that radiation can lead to electron density changes in the lung and liver, as observed from CT images. [14][15][16][17][18] The CT number (CTN) changes were found to be associated with radiation injuries.…”

Section: Introductionmentioning

confidence: 99%

Radiation-induced CT number changes in GTV and parotid glands during the course of radiation therapy for nasopharyngeal cancer

Yang

et al. 2016

BJR

View full text Add to dashboard Cite

Objective: To investigate the changes in CT number (CTN) in gross tumour volume (GTV) and organs at risk (OARs) during the course of radiation therapy (RT) for nasopharyngeal cancer (NPC). Methods: Daily megavoltage CT (MVCT) data collected from 30 patients with NPC treated with a prescription dose of 70 Gy in 30-33 fractions using helical tomotherapy were retrospectively analyzed. The contours of GTV and OARs on daily MVCTs were obtained by populating the planning contours from planning CT to daily MVCTs with manual editing, if necessary. The changes of GTV and OAR volumes and the histograms of CTN in the GTV and OARs during the course of RT delivery were analyzed. Results: Volumes of GTV and parotid glands were reduced during the course of radiation treatment, with an average shrinkage rate of 0.23% per day (range, 0.02-0.8%) and 1.2% per day (range, 0.2-2.3%), respectively. The mean CTN changes in GTV and ipsilateral and contralateral parotid glands were reduced by 52 6 35 HU, 18 6 20 HU and 17 6 22 HU, respectively. For GTV, the CTN and GTV volume decreases were found to be correlated with each other (p , 0.0001). No noticeable CTN change was found in the spinal cord and non-specified tissue irradiated with low doses. Conclusion: The CTN changes in GTV and parotids are measurable during the delivery of fractionated radiotherapy for NPC, were associated with the doses received (the number of fractions delivered) and were patient specific. Advances in knowledge: The CTN change during radiotherapy is dose dependent and is measurable for NPC.

show abstract

“…Given the improved local control and toxicity results reported by recent lung SBRT studies [1][2][3][4] , future directions for this technique include the treatment of larger lesions. Palma et al [5] and Diot et al [6] suggest that toxicity might increase with lesion size, and this possibility should be anticipated and closely monitored.…”

Section: Introductionmentioning

confidence: 99%

Radiation pneumonitis after stereotactic radiation therapy for lung cancer

Yamashita

Takahashi

Haga

et al. 2014

WJR

View full text Add to dashboard Cite

Stereotactic body radiation therapy (SBRT) has a local control rate of 95% at 2 years for non-small cell lung cancer (NSCLC) and should improve the prognosis of inoperable patients, elderly patients, and patients with significant comorbidities who have early-stage NSCLC. The safety of SBRT is being confirmed in international, multi-institutional Phase Ⅱ trials for peripheral lung cancer in both inoperable and operable patients, but reports so far have found that SBRT is a safe and effective treatment for early-stage NSCLC and early metastatic lung cancer. Radiation pneumonitis (RP) is one of the most common toxicities of SBRT. Although most post-treatment RP is Grade 1 or 2 and either asymptomatic or manageable, a few cases are severe, symptomatic, and there is a risk for mortality. The reported rates of symptomatic RP after SBRT range from 9% to 28%. Being able to predict the risk of RP after SBRT is extremely useful in treatment planning. A dose-effect relationship has been demonstrated, but suggested dose-volume factors like mean lung dose, lung V20, and/or lung V2.5 differed among the reports. We found that patients who present with an interstitial pneumonitis shadow on computed tomography scan and high levels of serum Krebs von den Lungen-6 and surfactant protein D have a high rate of severe radiation pneumonitis after SBRT. At our institution, lung cancer patients with these risk factors have not received SBRT since 2006, and our rate of severe RP after SBRT has decreased significantly since then.

show abstract

Lung Density Changes After Stereotactic Radiotherapy: A Quantitative Analysis in 50 Patients

Cited by 86 publications

References 25 publications

Texture analysis of medical images for radiotherapy applications

Texture analysis of medical images for radiotherapy applications

Radiation-induced CT number changes in GTV and parotid glands during the course of radiation therapy for nasopharyngeal cancer

Radiation pneumonitis after stereotactic radiation therapy for lung cancer

Contact Info

Product

Resources

About